The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Clinical trial NCT02581020 · COMPLETED

Trial details

NCT number: NCT02581020
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis C Virus

Start date: 2016-01-14
Primary completion: 2020-12-08
Enrollment: 344

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.